Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4029402 | Ophthalmology | 2008 | 7 Pages |
Abstract
Nonocular MCC is known to recur in 66% of patients and to be lethal in almost 33%. Merkel cell carcinoma of the eyelid is a rare malignancy that can not be recognized clinically. Clinical differential diagnosis must be made with a chalazion, and histopathologic differential diagnosis must be made with small cell carcinomas. Close follow-up of these patients is advised because of the potential high recurrence rate and lymphatic spread. The immunologic phenomenon of spontaneous regression points out the importance of the immune system in this disease.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Guy S. MD, PhD, D. MD, PhD, R.J.W. MD, PhD,